Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.

Saved in:
Bibliographic Details
Title: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Authors: Lauko, Adam1, Kotecha, Rupesh2,3, Barnett, Addison4, Li, Hong5, Tatineni, Vineeth6, Ali, Assad4, Patil, Pradnya7, Mohammadi, Alireza M.1,4,8, Chao, Samuel T.4,9, Murphy, Erin S.4,9, Angelov, Lilyana1,4,8, Suh, John H.4,9, Barnett, Gene H.1,4,8, Pennell, Nathan A.7, Ahluwalia, Manmeet S.3,10 manmeeta@baptisthealth.net
Source: Scientific Reports. 9/13/2021, Vol. 11 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Description
ISSN:20452322
DOI:10.1038/s41598-021-97566-z